Mechanistically, this is in line with a recent publication demonstrating that MCs activated via IL-33/ST2 release macrophage-attracting factors, including GM-CSF (CSF2), which promote tumor-associated macrophages responsible for tumor cell proliferation and angiogenesis in a preclinical model of gastric cancer (47). The gene discussed is IL33; the disease is gastric cancer.